Introductory remark :
In the context with the
so called
«Angelopharm»-sentence of the
European Court, the EC asked
the SCCNFP for an opinion on
the use of strontium and
strontium salts/derivatives in
cosmetic products, especially
Sr lactate, Sr nitrate, and Sr
polycarboxylate, listed at
present in Annex II of the
Cosmetic Directive 76/768 EEC.
Opinion :
Sr and Sr salts should
only be used as ingredients in
cosmetic products in the
chemical form and concentration
having been investigated,
evaluated and recommended by
the SCCNFP and listed under
these premises in the
respective parts of the
Cosmetic Directive 76/768 EEC.
As valid in general for
substances intended to be used
as ingredients of cosmetic
products, also for other Sr
derived compounds, new
submissions, following the
SCCNFP notes of guidance, have
to be presented.
Consequences :
The three mentioned Sr
derivatives, at present listed
in Annex II of the Cosmetic
Directive, have to be deleted
as their at present known
toxicological profiles do not
indicate safety issues for use
in cosmetic products and
consequently also Annex V of
the Cosmetic Directive has to
be adapted.